Erratum: Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma (Analytical and Bioanalytical Chemistry DOI: 10.1007/s00216-010-3979-y);Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma

Analytical and Bioanalytical Chemistry

Volumn 398, Issue 2, 2010, Pages 737-749

  Hawkridge, Adam M ^a   Wysocky, Rebecca B ^a   Petitte, James N ^a   Anderson, Kenneth E ^a   Mozdziak, Paul E ^a   Fletcher, Oscar J ^a   Horowitz, Jonathan M ^a   Muddiman, David C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Bioanalytical methods; Biological samples; Clinical biomedical analysis; Genomics proteomics; Mass spectrometry ICP MS

Indexed keywords

BIRDS; HISTOLOGY; MASS SPECTROMETRY; MOLECULAR BIOLOGY; TISSUE;

BIOANALYTICAL METHODS; BIOLOGICAL SAMPLES; CLINICAL/BIOMEDICAL ANALYSIS; GENOMICS/PROTEOMICS; MASS SPECTROMETRY/ICP-MS;

PROTEINS;

AVES; GALLUS GALLUS;

EID: 77957867631     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-4107-8     Document Type: Erratum

References (97)

1. Society AC (2009) Cancer facts and figures 2009. Atlanta
2. TI Williams KL Toups DA Saggese KR Kalli WA Cliby DC Muddiman 2007 Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers J Proteome Res 6 8 2936 2962 1:CAS:528:DC%2BD2sXms1Cjsrg%3D 10.1021/pr070041v (Pubitemid 47310180)
3. RC Bast Jr M Feeney H Lazarus LM Nadler RB Colvin RC Knapp 1981 Reactivity of a monoclonal antibody with human ovarian carcinoma J Clin Invest 68 5 1331 1337 10.1172/JCI110380
4. RC Bast Jr TL Klug E St John E Jenison JM Niloff H Lazarus RS Berkowitz T Leavitt CT Griffiths L Parker VR Zurawski Jr RC Knapp 1983 A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer N Engl J Med 309 15 883 887 10.1056/NEJM198310133091503
5. U Menon A Gentry-Maharaj R Hallett A Ryan M Burnell A Sharma S Lewis S Davies S Philpott A Lopes K Godfrey D Oram J Herod K Williamson MW Seif I Scott T Mould R Woolas J Murdoch S Dobbs NN Amso S Leeson D Cruickshank A McGuire S Campbell L Fallowfield N Singh A Dawnay SJ Skates M Parmar I Jacobs 2009 Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK collaborative trial of ovarian cancer screening Lancet Oncol 10 4 327 340 10.1016/S1470-2045(09)70026-9
6. MR Andersen BA Goff KA Lowe N Scholler L Bergan CW Dresher P Paley N Urban 2008 Combining a symptoms index with ca 125 to improve detection of ovarian cancer Cancer 113 3 484 489 10.1002/cncr.23577
7. N Auersperg AS Wong KC Choi SK Kang PC Leung 2001 Ovarian surface epithelium: biology, endocrinology, and pathology Endocr Rev 22 2 255 288 1:CAS:528:DC%2BD3MXjsFSntLs%3D 10.1210/er.22.2.255 (Pubitemid 32458162)
8. N Auersperg T Ota GW Mitchell 2002 Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches Int J Gynecol Cancer 12 6 691 703 1:STN:280:DC%2BD38novVSjuw%3D%3D 10.1046/j.1525-1438.2002. 01152.x (Pubitemid 35388036)
9. D Cvetkovic 2003 Early events in ovarian oncogenesis Reprod Biol Endocrinol 1 68 10.1186/1477-7827-1-68
10. BC Vanderhyden TJ Shaw JF Ethier 2003 Animal models of ovarian cancer Reprod Biol Endocrinol 1 67 10.1186/1477-7827-1-67 (Pubitemid 39130458)
11. RF Ozols MA Bookman DC Connolly MB Daly AK Godwin RJ Schilder X Xu TC Hamilton 2004 Focus on epithelial ovarian cancer Cancer Cell 5 1 19 24 1:CAS:528:DC%2BD2cXhtFGrsLg%3D 10.1016/S1535-6108(04)00002-9 (Pubitemid 38121593)
12. K Garson TJ Shaw KV Clark DS Yao BC Vanderhyden 2005 Models of ovarian cancer-are we there yet? Mol Cell Endocrinol 239 1-2 15 26 1:CAS:528: DC%2BD2MXlslylsLw%3D 10.1016/j.mce.2005.03.019 (Pubitemid 40848725)
13. RC Bast Jr B Hennessy GB Mills 2009 The biology of ovarian cancer: new opportunities for translation Nat Rev Cancer 9 6 415 428 1:CAS:528: DC%2BD1MXmt1Skt7g%3D 10.1038/nrc2644
14. Bartlett J (ed) (2000) Ovarian cancer methods and protocols. Methods in molecular medicine. Humana, Totowa
15. JS Liu G Yang JA Thompson-Lanza A Glassman K Hayes A Patterson RT Marquez N Auersperg YH Yu WC Hahn GB Mills RC Bast 2004 A genetically defined model for human ovarian cancer Cancer Res 64 5 1655 1663 1:CAS:528:DC%2BD2cXhslektbc%3D 10.1158/0008-5472.CAN-03-3380 (Pubitemid 38428686)
16. S Orsulic Y Li RA Soslow LA Vitale-Cross JS Gutkind HE Varmus 2002 Induction of ovarian cancer by defined multiple genetic changes in a mouse model system Cancer Cell 1 1 53 62 1:CAS:528:DC%2BD38XitlCmsbo%3D 10.1016/S1535-6108(01)00002-2 (Pubitemid 41039176)
17. DC Connolly R Bao AY Nikitin KC Stephens TW Poole X Hua SS Harris BC Vanderhyden TC Hamilton 2003 Female mice chimeric for expression of the simian virus 40 tag under control of the misiir promoter develop epithelial ovarian cancer Cancer Res 63 6 1389 1397 1:CAS:528:DC%2BD3sXit1Sgurk%3D
18. A Flesken-Nikitin KC Choi JP Eng EN Shmidt AY Nikitin 2003 Induction of carcinogenesis by concurrent inactivation of p53 and rb1 in the mouse ovarian surface epithelium Cancer Res 63 13 3459 3463 1:CAS:528:DC%2BD3sXltVGrtL8%3D
19. DM Dinulescu TA Ince BJ Quade SA Shafer D Crowley T Jacks 2005 Role of k-ras and pten in the development of mouse models of endometriosis and endometrioid ovarian cancer Nat Med 11 1 63 70 1:CAS:528:DC%2BD2MXptVSm 10.1038/nm1173 (Pubitemid 40215839)
20. Orsulic S (2004) Ovarian cancer. In: Holland EC (ed) Mouse models of human cancer. Wiley-Liss, Hoboken, pp 171-187
21. JE Wilson 1958 Adeno-carcinomata in hens kept in a constant environment Poult Sci 37 1253
22. TN Fredrickson 1987 Ovarian tumors of the hen Environ Health Perspect 73 35 51 1:STN:280:DyaL1c%2FivFaqug%3D%3D 10.2307/3430596
23. C Rodriguez-Burford MN Barnes W Berry EE Partridge WE Grizzle 2001 Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention Gynecol Oncol 81 3 373 379 1:CAS:528:DC%2BD3MXjslagu7g%3D 10.1006/gyno.2001.6191 (Pubitemid 32494650)
24. JR Giles LM Olson PA Johnson 2006 Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer Exp Biol Med 231 11 1718 1725 1:CAS:528:DC%2BD28XhtlSitrfI
25. ME Urick PA Johnson 2006 Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer Gynecol Oncol 103 2 673 678 1:CAS:528:DC%2BD28XhtFegur3K 10.1016/j.ygyno.2006.05.012 (Pubitemid 44602185)
26. E Jackson K Anderson C Ashwell J Petitte PE Mozdziak 2007 Ca125 expression in spontaneous ovarian adenocarcinomas from laying hens Gynecol Oncol 104 1 192 198 1:CAS:528:DC%2BD2sXkvF2ksQ%3D%3D 10.1016/j.ygyno.2006.07.024 (Pubitemid 46054125)
27. K Stammer SL Edassery A Barua P Bitterman JM Bahr DB Hales JL Luborsky 2008 Selenium-binding protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer Gynecol Oncol 109 1 115 121 1:CAS:528:DC%2BD1cXktVCis7c%3D 10.1016/j.ygyno.2007.12.030
28. AA Hakim CP Barry HJ Barnes KE Anderson J Petitte R Whitaker JM Lancaster RM Wenham DK Carver J Turbov A Berchuck L Kopelovich GC Rodriguez 2009 Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and her-2/neu Cancer Prev Res 2 2 114 121 1:CAS:528:DC%2BC3cXptFKgtbo%3D 10.1158/1940-6207.CAPR-08-0065
29. ME Urick JR Giles PA Johnson 2009 Dietary aspirin decreases the stage of ovarian cancer in the hen Gynecol Oncol 112 1 166 170 1:CAS:528: DC%2BD1cXhsFajs7fF 10.1016/j.ygyno.2008.09.032
30. MF Fathalla 1971 Incessant ovulation-a factor in ovarian neoplasia? Lancet 2 7716 163 1:STN:280:DyaE3M3ls12ltw%3D%3D 10.1016/S0140-6736(71)92335-X
31. AM Hawkridge DC Muddiman 2009 Mass spectrometry-based biomarker discovery: towards a global proteome index of individuality Ann Rev Anal Chem 2 265 278 1:CAS:528:DC%2BD1MXpsFaqsbk%3D 10.1146/annurev.anchem.1.031207.112942
32. VM Faca SM Hanash 2009 In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding Cancer Res 69 3 728 730 1:CAS:528:DC%2BD1MXhtFOks7g%3D 10.1158/0008-5472.CAN-08-3087
33. A Morita E Miyagi H Yasumitsu H Kawasaki H Hirano F Hirahara 2006 Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma Proteomics 6 21 5880 5890 1:CAS:528: DC%2BD28Xht1yqsbbK 10.1002/pmic.200500708 (Pubitemid 44764024)
34. DM Smith-Beckerman KW Fung KE Williams N Auersperg AK Godwin AL Burlingame 2005 Proteome changes in ovarian epithelial cells derived from women with brca1 mutations and family histories of cancer Mol Cell Proteomics 4 2 156 168 1:CAS:528:DC%2BD2MXhvFKnt7Y%3D
35. CG Gunawardana C Kuk CR Smith I Batruch A Soosaipillai EP Diamandis 2009 Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer J Proteome Res 8 10 4705 4713 1:CAS:528:DC%2BD1MXhtVOrs73J 10.1021/pr900411g
36. SJ Pitteri L JeBailey VM Faca JD Thorpe MA Silva RC Ireton MB Horton H Wang LC Pruitt Q Zhang KH Cheng N Urban SM Hanash DM Dinulescu 2009 Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery PLoS ONE 4 11 e7916 10.1371/journal.pone. 0007916
37. VM Faca AP Ventura MP Fitzgibbon SR Pereira-Faca SJ Pitteri AE Green RC Ireton Q Zhang H Wang KC O'Briant CW Drescher M Schummer MW McIntosh BS Knudsen SM Hanash 2008 Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains PLoS ONE 3 6 e2425 10.1371/journal.pone.0002425
38. Y Wang R Wu KR Cho DG Thomas G Gossner JR Liu TJ Giordano KA Shedden DE Misek DM Lubman 2009 Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage J Proteome Res 8 3 1452 1463 1:CAS:528:DC%2BD1MXpt1ensg%3D%3D 10.1021/pr800820z
39. H Wang MT Kachman DR Schwartz KR Cho DM Lubman 2004 Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers Proteomics 4 8 2476 2495 1:CAS:528:DC%2BD2cXmsFektbY%3D 10.1002/pmic.200300763 (Pubitemid 39025348)
40. QY He Y Zhou E Wong TG Ehlen N Auersperg JF Chiu AST Wong 2005 Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies Gynecol Oncol 98 1 68 76 1:CAS:528:DC%2BD2MXlt1Ggtbs%3D 10.1016/j.ygyno.2005.04.002 (Pubitemid 40826421)
41. S Bengtsson M Krogh CAK Szigyarto M Uhlen K Schedvins C Silfversward S Linder G Auer A Alaiya P James 2007 Large-scale proteomics analysis of human ovarian cancer for biomarkers J Proteome Res 6 4 1440 1450 1:CAS:528: DC%2BD2sXhvFKqu74%3D 10.1021/pr060593y (Pubitemid 46724042)
42. C Kuk V Kulasingam CG Gunawardana CR Smith I Batruch EP Diamandis 2009 Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers Mol Cell Proteomics 8 4 661 669 1:CAS:528:DC%2BD1MXksFWqtLc%3D 10.1074/mcp.M800313-MCP200
43. L Gortzak-Uzan A Ignatchenko AI Evangelou M Agochiya KA Brown PS Onge I Kireeva G Schmitt-Ulms TJ Brown J Murphy B Rosen P Shaw I Jurisica T Kislinger 2008 A proteome resource of ovarian cancer ascites: Integrated proteomic and bioinformatic analyses to identify putative biomarkers J Proteome Res 7 1 339 351 1:CAS:528:DC%2BD2sXhsVamsbvI 10.1021/pr0703223 (Pubitemid 351171148)
44. MF Lopez A Mikulskis S Kuzdzal E Golenko EF Petricoin 3rd LA Liotta WF Patton GR Whiteley K Rosenblatt P Gurnani A Nandi S Neill S Cullen M O'Gorman D Sarracino C Lynch A Johnson W McKenzie D Fishman 2007 A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples Clin Chem 53 6 1067 1074 1:CAS:528:DC%2BD2sXmtVOhsrs%3D 10.1373/clinchem.2006.080721 (Pubitemid 46867523)
45. N Ahmed KT Oliva G Barker P Hoffmann S Reeve IA Smith MA Quinn GE Rice 2005 Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer Proteomics 5 17 4625 4636 1:CAS:528:DC%2BD2MXht12nt7vI 10.1002/pmic.200401321 (Pubitemid 41739939)
46. SA Moshkovskii MV Serebryakova KB Kuteykin-Teplyakov OV Tikhonova EI Goufman VG Zgoda IN Taranets OV Makarov AI Archakov 2005 Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid a1 Proteomics 5 14 3790 3797 1:CAS:528:DC%2BD2MXhtVygtLnJ 10.1002/pmic.200401205 (Pubitemid 41393309)
47. N Ahmed G Barker KT Oliva P Hoffmann C Riley S Reeve AI Smith BE Kemp MA Quinn GE Rice 2004 Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer Br J Cancer 91 1 129 140 1:CAS:528:DC%2BD2cXlt1Ckt7o%3D 10.1038/sj.bjc.6601882 (Pubitemid 39013057)
48. B Ye DW Cramer SJ Skates SP Gygi V Pratomo L Fu NK Horick LJ Licklider JO Schorge RS Berkowitz SC Mok 2003 Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry Clin Cancer Res 9 8 2904 2911 1:CAS:528:DC%2BD3sXmtF2iu70%3D
49. HR Bergen G Vasmatzis WA Cliby KL Johnson AL Oberg DC Muddiman 2003 Discovery of ovarian cancer biomarkers in serum using nanoLC electrospray ionization TOF and FT-ICR mass spectrometry Dis Markers 19 4-5 239 249 1:CAS:528:DC%2BD2cXls1anurk%3D
50. Z Zhang RC Bast YH Yu JN Li LJ Sokoll AJ Rai JM Rosenzweig B Cameron YY Wang XY Meng A Berchuck C van Haaften-Day NF Hacker HWA de Bruijn AGJ van der Zee IJ Jacobs ET Fung DW Chan 2004 Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res 64 16 5882 5890 1:CAS:528:DC%2BD2cXmslaks7Y%3D 10.1158/0008-5472.CAN-04-0746 (Pubitemid 39095590)
51. E Cotlove EK Harris GZ Williams 1970 Biological and analytic components of variation in long-term studies of serum constituents in normal subjects 3. Physiological and medical implications Clin Chem 16 12 1028 1032 1:CAS:528:DyaE3MXosFaisA%3D%3D
52. EK Harris P Kanofsky G Shakarji E Cotlove 1970 Biological and analytic components of variation in long-term studies of serum constituents in normal subjects 2. Estimating biological components of variation Clin Chem 16 12 1022 1027 1:CAS:528:DyaE3MXmtFGmtg%3D%3D
53. GZ Williams DS Young MR Stein E Cotlove 1970 Biological and analytic components of variation in long-term studies of serum constituents in normal subjects I. Objectives, subject selection, laboratory procedures, and estimation of analytic deviation Clin Chem 16 12 1016 1021 1:CAS:528:DyaE3MXmtFGmsQ%3D%3D
54. EK Harris DL Demets 1971 Biological and analytic components of variation in long-term studies of serum constituents in normal subjects 5. Estimated biological variations in ionized calcium Clin Chem 17 10 983 987 1:CAS:528:DyaE3MXlsV2mu7w%3D
55. DS Young EK Harris E Cotlove 1971 Biological and analytic components of variation in long-term studies of serum constituents in normal subjects 4. Results of a study design to eliminate long-term analytic deviations Clin Chem 17 5 403 410 1:CAS:528:DyaE3MXksVKgs70%3D
56. EK Harris 1974 Effects of intraindividual and interindividual variation on appropriate use of normal ranges Clin Chem 20 12 1535 1542 1:CAS:528:DyaE2MXntVSqtQ%3D%3D
57. McPherson RA, Pincus MR (eds) (2007) Henry's clinical diagnosis and management by laboratory methods, 21st edn. Saunders Elsevier, Philadelphia
58. MK Tuxen G Soletormos PH Petersen V Schioler P Dombernowsky 1999 Assessment of biological variation and analytical imprecision of ca 125, cea, and tpa in relation to monitoring of ovarian cancer Gynecol Oncol 74 1 12 22 1:CAS:528:DyaK1MXktVWmsrg%3D 10.1006/gyno.1999.5414 (Pubitemid 29331162)
59. MK Tuxen G Soletormos GJ Rustin AE Nelstrop P Dombernowsky 2000 Biological variation and analytical imprecision of ca 125 in patients with ovarian cancer Scand J Clin Lab Invest 60 8 713 721 1:STN:280: DC%2BD3M7ptl2isQ%3D%3D 10.1080/00365510050216448 (Pubitemid 32094666)
60. SJ Skates FJ Xu YH Yu K Sjovall N Einhorn Y Chang RC Bast Jr RC Knapp 1995 Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers Cancer 76 10 2004 2010 1:STN:280:DyaK283ivF2lug%3D%3D 10.1002/1097-0142(19951115)76:10+<2004::AID-CNCR2820761317>3.0.CO;2-G
61. G Soletormos V Schioler D Nielsen T Skovsgaard P Dombernowsky 1993 Interpretation of results for tumor-markers on the basis of analytical imprecision and biological variation Clin Chem 39 10 2077 2083 1:CAS:528:DyaK2cXjslGk
62. Richardson RW (1994) Handbook of nonpathologic variations in human blood constituents. CRC
63. Harris EK, Boyd JC (1995) Statistical bases of reference values in laboratory medicine, vol 146. Statistics: textbooks and monographs. Marcel Dekker, New York
64. NL Anderson NG Anderson 2002 The human plasma proteome-history, character, and diagnostic prospects Mol Cell Proteomics 1 11 845 867 1:CAS:528:DC%2BD3sXht1Ciug%3D%3D 10.1074/mcp.R200007-MCP200
65. MT Davis P Auger C Spahr SD Patterson 2007 Cancer biomarker discovery via low molecular weight serum proteome profiling - where is the tumor? Proteonomics Clin Appl 1 12 1545 1558 1:CAS:528:DC%2BD1cXmvA%3D%3D 10.1002/prca.200700141
66. G Candiano M Bruschi L Musante L Santucci GM Ghiggeri B Carnemolla P Orecchia L Zardi PG Righetti 2004 Blue silver: a very sensitive colloidal Coomassie g-250 staining for proteome analysis Electrophoresis 25 9 1327 1333 1:CAS:528:DC%2BD2cXks12ht7c%3D 10.1002/elps.200305844 (Pubitemid 38801651)
67. A Shevchenko H Tomas J Havlis JV Olsen M Mann 2006 In-gel digestion for mass spectrometric characterization of proteins and proteomes Nat Prot 1 6 2856 2860 1:CAS:528:DC%2BD2sXhtFGjt7nM 10.1038/nprot.2006.468
68. GL Andrews CM Shuford JC Burnett AM Hawkridge DC Muddiman 2009 Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection of brain natriuretic peptide-32 and its proteolytic peptides J Chromatogr B 877 10 948 954 1:CAS:528:DC%2BD1MXjsFWkt7w%3D 10.1016/j.jchromb. 2009.02.040
69. A Keller AI Nesvizhskii E Kolker R Aebersold 2002 Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal Chem 74 20 5383 5392 1:CAS:528:DC%2BD38XmvVyktL4%3D 10.1021/ac025747h (Pubitemid 35215372)
70. AI Nesvizhskii A Keller E Kolker R Aebersold 2003 A statistical model for identifying proteins by tandem mass spectrometry Anal Chem 75 17 4646 4658 1:CAS:528:DC%2BD3sXltlynt70%3D 10.1021/ac0341261 (Pubitemid 37082259)
71. DB Weatherly JA Atwood TA Minning C Cavola RL Tarleton R Orlando 2005 A heuristic method for assigning a false-discovery rate for protein identifications from mascot database search results Mol Cell Proteomics 4 6 762 772 1:CAS:528:DC%2BD2MXlsV2nsrs%3D 10.1074/mcp.M400215-MCP200 (Pubitemid 40873005)
72. SE Ong M Mann 2005 Mass spectrometry-based proteomics turns quantitative Nat Chem Biol 1 5 252 262 1:CAS:528:DC%2BD2MXhtVamtrfI 10.1038/nchembio736
73. D Chelius PV Bondarenko 2002 Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry J Proteome Res 1 4 317 323 1:CAS:528:DC%2BD38Xkt1Cksrk%3D 10.1021/pr025517j (Pubitemid 36395872)
74. PV Bondarenko D Chelius TA Shaler 2002 Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry Anal Chem 74 18 4741 4749 1:CAS:528:DC%2BD38Xmt1Slur0%3D 10.1021/ac0256991
75. WX Wang HH Zhou H Lin S Roy TA Shaler LR Hill S Norton P Kumar M Anderle CH Becker 2003 Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards Anal Chem 75 18 4818 4826 1:CAS:528:DC%2BD3sXmtVKlur0%3D 10.1021/ac026468x (Pubitemid 37139783)
76. RE Higgs MD Knierman V Gelfanova JP Butler JE Hale 2005 Comprehensive label-free method for the relative quantification of proteins from biological samples J Proteome Res 4 4 1442 1450 1:CAS:528:DC%2BD2MXlsVeks7w%3D 10.1021/pr050109b (Pubitemid 41208703)
77. KL Johnson CJ Mason DC Muddiman JE Eckel 2004 Analysis of the low molecular weight fraction of serum by LC-dual ESI-FT-ICR mass spectrometry: precision of retention time, mass, and ion abundance Anal Chem 76 17 5097 5103 1:CAS:528:DC%2BD2cXmtF2ktbo%3D 10.1021/ac0497003 (Pubitemid 39180339)
78. AC Paoletti TJ Parmely C Tomomori-Sato S Sato DX Zhu RC Conaway JW Conaway L Florens MP Washburn 2006 Quantitative proteomic analysis of distinct mammalian mediator complexes using normalized spectral abundance factors Proc Nat Acad Sci USA 103 50 18928 18933 1:CAS:528:DC%2BD28XhtlChu77P 10.1073/pnas.0606379103 (Pubitemid 350002805)
79. J Rappsilber U Ryder AI Lamond M Mann 2002 Large-scale proteomic analysis of the human splicesome Genome Res 12 8 1231 1245 1:CAS:528: DC%2BD38Xmtl2rur4%3D 10.1101/gr.473902 (Pubitemid 41264425)
80. HB Liu RG Sadygov JR Yates 2004 A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal Chem 76 14 4193 4201 1:CAS:528:DC%2BD2cXksVKiur8%3D 10.1021/ac0498563 (Pubitemid 38943698)
81. MC Wiener JR Sachs EG Deyanova NA Yates 2004 Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures Anal Chem 76 20 6085 6096 1:CAS:528:DC%2BD2cXnsFOgtrg%3D 10.1021/ac0493875 (Pubitemid 39382956)
82. Y Ishihama Y Oda T Tabata T Sato T Nagasu J Rappsilber M Mann 2005 Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein Mol Cell Proteomics 4 9 1265 1272 1:CAS:528:DC%2BD2MXhtVGhu7nL 10.1074/mcp.M500061-MCP200 (Pubitemid 41448714)
83. N Pavelka ML Fournier SK Swanson M Pelizzola P Ricciardi-Castagnoli L Florens MP Washburn 2008 Statistical similarities between transcriptomics and quantitative shotgun proteomics data Mol Cell Proteomics 7 4 631 644 1:CAS:528:DC%2BD1cXltlWnsbg%3D
84. H Choi D Fermin AI Nesvizhskii 2008 Significance analysis of spectral count data in label-free shotgun proteomics Mol Cell Proteomics 7 12 2373 2385 1:CAS:528:DC%2BD1cXhsFahtrzM 10.1074/mcp.M800203-MCP200
85. B Zhang NC VerBerkmoes MA Langston E Uberbacher RL Hettich NF Samatova 2006 Detecting differential and correlated protein expression in label-free shotgun proteomics J Proteome Res 5 11 2909 2918 1:CAS:528:DC%2BD28XhtVGmsbvI 10.1021/pr0600273 (Pubitemid 44749209)
86. J Colinge D Chiappe S Lagache M Moniatte L Bougueleret 2005 Differential proteomics via probabilistic peptide identification scores Anal Chem 77 2 596 606 1:CAS:528:DC%2BD2cXhtVKit7bL 10.1021/ac0488513 (Pubitemid 40116841)
87. WM Old K Meyer-Arendt L Aveline-Wolf KG Pierce A Mendoza JR Sevinsky KA Resing NG Ahn 2005 Comparison of label-free methods for quantifying human proteins by shotgun proteomics Mol Cell Proteomics 4 10 1487 1502 1:CAS:528:DC%2BD2MXhtFeltbzI 10.1074/mcp.M500084-MCP200 (Pubitemid 41555475)
88. BB Gao L Stuart EP Feener 2008 Label-free quantitative analysis of one-dimensional page LC/MS/MS proteome Mol Cell Proteomics 7 12 2399 2409 1:CAS:528:DC%2BD1cXhsFeru7zF 10.1074/mcp.M800104-MCP200
89. Whittow GC (ed) (2000) Sturkie's avian physiology. Reproduction in the female, 5th edn. Academic, San Diego
90. H Nagase ED Harris JF Woessner K Brew 1983 Ovostatin-a novel proteinase-inhibitor from chicken egg-white 1. Purification, physicochemical properties, and tissue distribution of ovostatin J Biol Chem 258 12 7481 7489 1:CAS:528:DyaL3sXkvVChs7g%3D
91. I Saxena S Tayyab 1997 Protein proteinase inhibitors from avian egg whites Cell Mol Life Sci 53 1 13 23 1:CAS:528:DyaK2sXhs1yhtrg%3D 10.1007/PL00000575 (Pubitemid 27379369)
92. K Mann 2007 The chicken egg white proteome Proteomics 7 19 3558 3568 1:CAS:528:DC%2BD2sXht1ersrbN 10.1002/pmic.200700397 (Pubitemid 47597677)
93. JR Barr VL Maggio DG Patterson GR Cooper LO Henderson WE Turner SJ Smith WH Hannon LL Needham EJ Sampson 1996 Isotope dilution mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I Clin Chem 42 10 1676 1682 1:CAS:528:DyaK28Xmt1eqsLg%3D
94. DR Barnidge MK Goodmanson GG Klee DC Muddiman 2004 Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry J Proteome Res 3 3 644 652 1:CAS:528:DC%2BD2cXivFOjsr8%3D 10.1021/pr049963d (Pubitemid 39207371)
95. DK Williams DC Muddiman 2009 Absolute quantification of c-reactive protein in human plasma derived from patients with epithelial ovarian cancer utilizing protein cleavage isotope dilution mass spectrometry J Proteome Res 8 2 1085 1090 1:CAS:528:DC%2BD1MXisVahtA%3D%3D 10.1021/pr800922p
96. E Kuhn J Wu J Karl H Liao W Zolg B Guild 2004 Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and C-13-labeled peptide standards Proteomics 4 4 1175 1186 1:CAS:528:DC%2BD2cXjt1Smtb8%3D 10.1002/pmic.200300670 (Pubitemid 38445974)
97. CS Spahr MT Davis MD McGinley JH Robinson EJ Bures J Beierle J Mort PL Courchesne K Chen RC Wahl W Yu R Luethy SD Patterson 2001 Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry I. Profiling an unfractionated tryptic digest Proteomics 1 1 93 107 1:CAS:528:DC%2BD3MXhtVGgs7s%3D 10.1002/1615-9861(200101)1:1<93::AID- PROT93>3.0.CO;2-3 (Pubitemid 33791876)